Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revelox is a Quebec-based consumer health and wellness company focused on supplements and skincare products positioned around a holistic "inside-out" well-aging concept. Founded in 2012 by Luce Duchaussoy, the company markets hyaluronic acid-centered nutritional supplements and topical skincare intended to support skin hydration, tissue vitality, and joint comfort. Since 2017, Revelox has described itself as operating as its own brand for the development of supplements and skincare, with formulas designed and manufactured in Quebec. Its commercial portfolio includes branded supplement products such as EtikHA, DermaLux, HAXtra, PureHA Advanced Formula, and Novisyn+, along with skincare products sold under Revelox and KAHMA. Revelox appears to be a commercial wellness/nutraceutical brand rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revelox.